| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/09/2011 | EP1947111B1 Mucin glycoprotein and use thereof |
| 02/09/2011 | EP1725659B1 Natural igm antibodies and inhibitors thereof |
| 02/09/2011 | EP1636561B1 Combinatorial protein library screening by periplasmic expression |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | EP1181313B1 Peptides for vaccinating against human cmv |
| 02/09/2011 | EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN1969046B Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof |
| 02/09/2011 | CN101970462A Cyclic compound and salt thereof |
| 02/09/2011 | CN101970461A Short fatty acid tail polymyxin derivatives and uses thereof |
| 02/09/2011 | CN101970460A Functional lipid constructs |
| 02/09/2011 | CN101970456A Tag peptide and use thereof |
| 02/09/2011 | CN101969989A Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 02/09/2011 | CN101092451B Solid phase synthesis method for PT 141 and MT II |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884184 comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region; suppressing an antigen-specific immune response to a target antigen; Autoimmune disease |
| 02/08/2011 | US7884183 Compounds for targeting endothelial cells, compositions containing the same and methods for their use |
| 02/08/2011 | US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation |
| 02/08/2011 | US7884074 Compounds and methods for prevention and/or treatment of inflammation using the same |
| 02/08/2011 | US7884071 Gels containing luteinizing hormone releasing hormone antagonist (ozarelix) in lyophilized form, aqueous solution of sodium chloride; colloids; for treating hormone related disorders, prostate cancer, breat cancer, uterine myomas, endometriosis, puberty disorders, and reproductive disorders |
| 02/08/2011 | US7884067 Peptides derived from cadherin and methods of use thereof |
| 02/08/2011 | US7883888 Replication incompetent Adenovirus (AdV) vectors, selectively killing cancer cells |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/03/2011 | WO2011014707A2 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | WO2011014594A1 Peptide-polymer cell culture articles and methods of making |
| 02/03/2011 | WO2011014025A2 Derivative of hydroxy-cinnamic acid in which a peptide has been bonded, production method for same, and cosmetic composition comprising same |
| 02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013698A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | US20110030103 Lipopeptides and lipopeptide synthetases |
| 02/03/2011 | US20110028403 HSP70-Based Treatment for Autoimmune Diseases and Cancer |
| 02/03/2011 | US20110028402 Substance p-saporin (sp-sap) conjugates and methods of use |
| 02/03/2011 | US20110028401 Cripto blocking molecules and therapeutic uses thereof |
| 02/03/2011 | US20110028395 Peptide modulators of angiogenesis and use thereof |
| 02/03/2011 | US20110028394 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110028316 Carbon nanotube binding peptides |
| 02/03/2011 | US20110028315 Carbon nanotube binding peptides |
| 02/03/2011 | US20110027347 Polymersomes and methods of making and using thereof |
| 02/03/2011 | US20110027303 Partial peptide of survivin presented on mhc class ii molecule and use therof |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027294 Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027176 Homing peptide for tumor vasculature |
| 02/03/2011 | US20110027175 Cancer imaging and treatment |
| 02/03/2011 | DE102009034779A1 Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen Synthetic analogues of bacterial lipopeptides and their use for the therapy and prophylaxis of allergic diseases |
| 02/03/2011 | CA2769525A1 Therapeutic agents for reducing parathyroid hormone levels |
| 02/02/2011 | EP2280031A1 Cancer antigens based on products of the tumor suppressor gene WT1 |
| 02/02/2011 | EP2280027A2 New antitumoral compounds |
| 02/02/2011 | EP2280026A2 New antitumoral compounds |
| 02/02/2011 | EP2280025A2 New antitumoral compounds |
| 02/02/2011 | EP2280024A2 Polypeptide specifically coupled to phosphatidylserine and use thereof |
| 02/02/2011 | EP2280023A1 Tumor-associated peptides which bind to MHC molecules |
| 02/02/2011 | EP2280022A1 Cripto blocking molecules and therapeutic uses thereof |
| 02/02/2011 | EP2279759A2 Compounds and methods for 18F labeled agents |
| 02/02/2011 | EP2279757A2 Compounds for targeting endothelial cells |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279413A2 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample |
| 02/02/2011 | EP2279203A2 Prion epitopes and methods of use thereof |
| 02/02/2011 | EP2279201A1 Peptides for targeting apoptotic cells and uses thereof |
| 02/02/2011 | EP2279200A1 Biologically active peptides |
| 02/02/2011 | EP2279199A1 Peptide homing to brain tumors |
| 02/02/2011 | CN101965358A Bombesin analog peptide antagonist conjugates |
| 02/02/2011 | CN101965357A Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 02/02/2011 | CN101965356A Polypeptide specifically bound to phosphatidylserine and the use thereof |
| 02/02/2011 | CN101962401A Polypeptin and preparation and application thereof |
| 02/02/2011 | CN101962400A Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 02/02/2011 | CN101260147B Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879574 Folded peptide backbone each end of which is conjugated to a fluorophore, which when cleaved as by digestion with a protease, the fluorophores provide high intensity signals; histology |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 01/27/2011 | WO2011011342A1 Synthesis of desmopressin |
| 01/27/2011 | WO2011010372A1 Method and kit for evaluation of substance, method for screening of substance, and method and kit for determination of presence of occurrence of diabetic nephropathy or potential risk of diabetic nephropathy |
| 01/27/2011 | WO2011009944A1 Compounds modulators of vegf activity and uses thereof |
| 01/27/2011 | WO2011009152A1 Vaccine |
| 01/27/2011 | WO2010141811A3 Compounds and methods for treating bone disorders and controlling weight |
| 01/27/2011 | WO2010009065A3 Amphipathic peptide compositions |
| 01/27/2011 | WO2009153294A8 Use of a tpb salt for the separation of biomolecules |
| 01/27/2011 | US20110021748 Non-Natural Peptides as Models for the Development of Antibiotics |
| 01/27/2011 | US20110021747 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/27/2011 | US20110021419 Methods and Compositions for the Treatment of Heart Failure and Other Disorders |
| 01/27/2011 | US20110021411 Reverse protein |
| 01/27/2011 | US20110021348 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020906 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020905 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020904 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020903 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020902 Carbon nanotube binding peptides |
| 01/27/2011 | US20110020842 eEF2K Assays for Identifying Compounds that Inhibit eEF2K Activity |
| 01/27/2011 | US20110020800 Characterization of BBK07 antigen of Borrelia burgdorferi and methods of use |
| 01/27/2011 | US20110020437 Oligopeptidic compounds and uses thereof |
| 01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |